REVIEW PAPER
Figure from article: Therapeutic Potential of...
 
HIGHLIGHTS
  • Arterial thrombosis arises from endothelial injury, hypercoagulability, and stasis mechanisms.
  • Fabaceae plants provide diverse phytochemicals with antiplatelet and anticoagulant potential.
  • Flavonoids, tannins, saponins, and phenolics target multiple thrombotic pathways simultaneously.
  • Dietary strategies support cardiovascular health and may reduce thrombotic risks.
  • Computational approaches accelerate discovery of plant-derived antithrombotic agents.
KEYWORDS
TOPICS
ABSTRACT
Arterial thrombosis (ATh) has been conventionally observed in distinct circumstances, with alterations in risk factors, pathology and treatment since 17.5 million people got affected by cardiovascular diseases (CVDs) in 2012, with 31% of universal deaths annually. Blood coagulation is a vigorous functional process in the human body that is exaggerated by internal and external factors. Similarly, numerous inherited and acquired defects in the coagulation process are also the causative agent for several health-related problems in humans. Currently, many drugs have been approved and used for the treatment of arterial thrombosis but, those drugs are made of chemicals and result in serious health effects. As a result of problems associated with synthetic drugs, many researchers are focussing on alternative medication and looking for substitute treatments. Plants-based experimental studies have shown their significant role in the alternative treatment of thrombosis. Conversely, traditional medicinal plants-derived novel cardiovascular drugs can be used to prevent blood coagulation and treat ATh through various mechanisms. Recently, a wide range of medicinal plants from the family of Fabaceae were used enormously as antithrombotic agents due to their powerful antithrombotic activity. The current review focuses on ATh and its risk factors, diet and prevention methods using medicinal plants from the family Fabaceae and discovering their latent use in the progress of novel multifunctional medications against thrombosis.
ABBREVIATIONS
ACE: Angiotensin-Converting Enzyme
ADMET: Absorption, Distribution, Metabolism, Excretion and Toxicity
ADP: Adenosine Diphosphate
AI: Artificial Intelligence
AT: Arterial Thrombosis
BP: Blood Pressure
CVD: Cardiovascular Disease
DASH: Dietary Approaches to Stop Hypertension
DVT: Deep Vein Thrombosis
eNOS: Endothelial Nitric Oxide Synthase
GP: Glycoprotein
GPVI: Glycoprotein VI
HRT: Hormone Replacement Therapy
ICAM-1: Intercellular Adhesion Molecule-1
LDL: Low-Density Lipoprotein
MI: Myocardial Infarction
MUFA: Monounsaturated Fatty Acids
NO: Nitric Oxide
OC: Oral Contraceptive
PAI-1: Plasminogen Activator Inhibitor-1
PAR-1: Protease-Activated Receptor-1
PE: Pulmonary Embolism
PI3K: Phosphoinositide 3-Kinase
PLCγ2: Phospholipase C Gamma 2
P2Y12: P2Y Purinoceptor 12
PUFA: Polyunsaturated Fatty Acids
RBC: Red Blood Cell
ROS: Reactive Oxygen Species
SFA: Saturated Fatty Acids
TFA: Trans Fatty Acids
TP: Thromboxane Prostanoid Receptor
tPA: Tissue Plasminogen Activator
TXA₂: Thromboxane A₂
uPA: Urokinase-Type Plasminogen Activator
VCAM-1: Vascular Cell Adhesion Molecule-1
VTE: Venous Thromboembolism
VWF: von Willebrand Factor
ACKNOWLEDGEMENTS
The author thanks and acknowledge the Management of Thiagarajar College, Madurai for providing necessary facility.
FUNDING
This research received no external funding. All work was conducted using institutional resources without dedicated grant support.
CONFLICT OF INTEREST
The authors declare that they have no known financial, personal, academic, or other relationships that could inappropriately influence, or be perceived to influence, the work reported in this manuscript. The authors confirm that there are no competing interests to declare.
PEER REVIEW INFORMATION
Article has been screened for originality
© 2026 The Author(s). This article is distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).
REFERENCES (86)
1.
Abbasi E, Khodadadi I. (2025), High-fat diet may increase the risk of insulin resistance by inducing dysbiosis, Metabol Open, 27:100381. doi:10.1016/j.metop.2025.100381. PMID: 40741424.
 
2.
Abd Ghani MF, Othman R, Nordin N. (2020), Molecular Docking Study of Naturally Derived Flavonoids with Antiapoptotic BCL-2 and BCL-XL Proteins toward Ovarian Cancer Treatment, J Pharm Bioallied Sci, 12(Suppl 2):S676-S680. doi:10.4103/jpbs.JPBS_272_19. PMID: 33828360.
 
3.
Abenavoli L, Kobyliak N, Kukharchuk A, Chervona O, Shvets Y, Scarlata GGM, Morano D, Christian E, Molochek N, Lynchak O, Hnativ Y, Falalyeyeva T. (2026), The Mediterranean diet: historical benefits and contemporary challenges in Southern Italy, Nutr Res, 145:37-47. doi:10.1016/j.nutres.2025.11.010. PMID: 41411692.
 
4.
Afrifa D, Engelbrecht L, Eijnde BO, Terblanche E. (2023), The health benefits of rooibos tea in humans (aspalathus linearis)-a scoping review, J Public Health Afr, 14(12):2784. doi:10.4081/jphia.2023.2784. PMID: 38204815.
 
5.
Ajay VS, Prabhakaran D. (2010), Coronary heart disease in Indians: implications of the INTERHEART study, Indian J Med Res, 132(5):561-6. doi:10.4103/0971-5916.73396. PMID: 21150008.
 
6.
Aleman MM, Walton BL, Byrnes JR, Wolberg AS. (2014), Fibrinogen and red blood cells in venous thrombosis, Thromb Res, 133 Suppl 1(0 1):S38-40. doi:10.1016/j.thromres.2014.03.017. PMID: 24759140.
 
7.
Asada Y, Yamashita A, Sato Y, Hatakeyama K. (2020), Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques, Pathol Int, 70(6):309-322. doi:10.1111/pin.12921. PMID: 32166823.
 
8.
Badulescu OV, Ciocoiu M, Vladeanu MC, Huzum B, Plesoianu CE, Iliescu-Halitchi D, Bojan A, Iliescu-Halitchi C, Bojan IB. (2025), The Role of Platelet Dysfunctions in the Pathogenesis of the Hemostatic-Coagulant System Imbalances, Int J Mol Sci, 26(6) doi:10.3390/ijms26062756. PMID: 40141398.
 
9.
Barbic F, Heusser K, Minonzio M, Shiffer D, Cairo B, Tank J, Jordan J, Diedrich A, Gauger P, Zamuner RA, Porta A, Furlan R. (2019), Effects of Prolonged Head-Down Bed Rest on Cardiac and Vascular Baroreceptor Modulation and Orthostatic Tolerance in Healthy Individuals, Front Physiol, 10:1061. doi:10.3389/fphys.2019.01061. PMID: 31507438.
 
10.
Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. (2021), Ten things to know about ten cardiovascular disease risk factors, Am J Prev Cardiol, 5:100149. doi:10.1016/j.ajpc.2021.100149. PMID: 34327491.
 
11.
Blann AD, Dunmore S. (2011), Arterial and venous thrombosis in cancer patients, Cardiol Res Pract, 2011:394740. doi:10.4061/2011/394740. PMID: 21403876.
 
12.
Casas R, Sacanella E, Urpi-Sarda M, Chiva-Blanch G, Ros E, Martinez-Gonzalez MA, Covas MI, Rosa Ma L-R, Salas-Salvado J, Fiol M, Aros F, Estruch R. (2014), The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial, PLoS One, 9(6):e100084. doi:10.1371/journal.pone.0100084. PMID: 24925270.
 
13.
Chen L, Luo S, Feng M, Chandra A, Baizabal-Carvallo JF, Mofatteh M, Wu J, He Y, Chen Z, Zeng X, Tu J, Wang X, Liao X. (2025), Decoding the link between ischemic stroke and myocardial infarction: a pathophysiological and clinical perspective, Eur J Med Res, 30(1):984. doi:10.1186/s40001-025-03221-y. PMID: 41102842.
 
14.
Chiu S, Bergeron N, Williams PT, Bray GA, Sutherland B, Krauss RM. (2016), Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial, Am J Clin Nutr, 103(2):341-7. doi:10.3945/ajcn.115.123281. PMID: 26718414.
 
15.
Davis C, Bryan J, Hodgson J, Murphy K. (2015), Definition of the Mediterranean Diet; a Literature Review, Nutrients, 7(11):9139-53. doi:10.3390/nu7115459. PMID: 26556369.
 
16.
Diab A, Dastmalchi LN, Gulati M, Michos ED. (2023), A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?, Vasc Health Risk Manag, 19:237-253. doi:10.2147/VHRM.S379874. PMID: 37113563.
 
17.
Dong T, Guo M, Zhang P, Sun G, Chen B. (2020), The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis, PLoS One, 15(1):e0225348. doi:10.1371/journal.pone.0225348. PMID: 31935216.
 
18.
Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. (2013), Nutritional recommendations for cardiovascular disease prevention, Nutrients, 5(9):3646-83. doi:10.3390/nu5093646. PMID: 24067391.
 
19.
Ekor M. (2014), The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety, Front Pharmacol, 4:177. doi:10.3389/fphar.2013.00177. PMID: 24454289.
 
20.
Esmon CT. (2009), Basic mechanisms and pathogenesis of venous thrombosis, Blood Rev, 23(5):225-9. doi:10.1016/j.blre.2009.07.002. PMID: 19683659.
 
21.
Estevez B, Du X. (2017), New Concepts and Mechanisms of Platelet Activation Signaling, Physiology (Bethesda), 32(2):162-177. doi:10.1152/physiol.00020.2016. PMID: 28228483.
 
22.
Flumignan CD, Nakano LC, Baptista-Silva JC, Flumignan RL. (2022), Antiplatelet agents for the treatment of deep venous thrombosis, Cochrane Database Syst Rev, 7(7):CD012369. doi:10.1002/14651858.CD012369.pub2. PMID: 35876829.
 
23.
Frak W, Wojtasinska A, Lisinska W, Mlynarska E, Franczyk B, Rysz J. (2022), Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease, Biomedicines, 10(8) doi:10.3390/biomedicines10081938. PMID: 36009488.
 
24.
Fuster JJ, Ouchi N, Gokce N, Walsh K. (2016), Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease, Circ Res, 118(11):1786-807. doi:10.1161/CIRCRESAHA.115.306885. PMID: 27230642.
 
25.
Gao M, Jebb SA, Aveyard P, Ambrosini GL, Perez-Cornago A, Carter J, Sun X, Piernas C. (2021), Associations between dietary patterns and the incidence of total and fatal cardiovascular disease and all-cause mortality in 116,806 individuals from the UK Biobank: a prospective cohort study, BMC Med, 19(1):83. doi:10.1186/s12916-021-01958-x. PMID: 33882922.
 
26.
Gimbrone MA, Jr., Garcia-Cardena G. (2016), Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis, Circ Res, 118(4):620-36. doi:10.1161/CIRCRESAHA.115.306301. PMID: 26892962.
 
27.
Gongora MC, Wenger NK. (2015), Cardiovascular Complications of Pregnancy, Int J Mol Sci, 16(10):23905-28. doi:10.3390/ijms161023905. PMID: 26473833.
 
28.
Gusev E, Sarapultsev A. (2023), Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes, Int J Mol Sci, 24(9) doi:10.3390/ijms24097910. PMID: 37175617.
 
29.
Hale MM, Medina SH. (2022), Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies, Mol Pharm, 19(12):4453-4465. doi:10.1021/acs.molpharmaceut.2c00626. PMID: 36149250.
 
30.
Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L. (2022), Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications, Cells, 11(20) doi:10.3390/cells11203214. PMID: 36291080.
 
31.
Heit JA, Spencer FA, White RH. (2016), The epidemiology of venous thromboembolism, J Thromb Thrombolysis, 41(1):3-14. doi:10.1007/s11239-015-1311-6. PMID: 26780736.
 
32.
Heraudeau A, Delluc A, Le Henaff M, Lacut K, Leroyer C, Desrues B, Couturaud F, Tromeur C. (2018), Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study, PLoS One, 13(5):e0194973. doi:10.1371/journal.pone.0194973. PMID: 29775482.
 
33.
Howard BJ, Fraser SF, Sethi P, Cerin E, Hamilton MT, Owen N, Dunstan DW, Kingwell BA. (2013), Impact on hemostatic parameters of interrupting sitting with intermittent activity, Med Sci Sports Exerc, 45(7):1285-91. doi:10.1249/MSS.0b013e318285f57e. PMID: 23439415.
 
34.
Hu T, Bazzano LA. (2014), The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies, Nutr Metab Cardiovasc Dis, 24(4):337-43. doi:10.1016/j.numecd.2013.12.008. PMID: 24613757.
 
35.
Joshi T, Mandal SK, Puri S, Asati V, Deepa PR, Sharma PK. (2023), Investigating the antioxidant activity enhancer effect of Cyamopsis tetragonoloba seed extract on phenolic phytochemicals, Front Plant Sci, 14:1131173. doi:10.3389/fpls.2023.1131173. PMID: 36968395.
 
36.
Karakasis P, Theofilis P, Patoulias D, Vlachakis PK, Antoniadis AP, Fragakis N. (2025), Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies, Int J Mol Sci, 26(5) doi:10.3390/ijms26052196. PMID: 40076813.
 
37.
Kaur A, Kumar R. (2025), Use of Herbal Drugs in Cardiovascular Disease- A Review, Curr Cardiol Rev, 21(1):e1573403X323724. doi:10.2174/011573403X323724240830075719. PMID: 39229989.
 
38.
Kearsley R, Stocks G. (2021), Venous thromboembolism in pregnancy-diagnosis, management, and treatment, BJA Educ, 21(3):117-123. doi:10.1016/j.bjae.2020.10.003. PMID: 33664981.
 
39.
Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. (2011), Deep vein thrombosis: a clinical review, J Blood Med, 2:59-69. doi:10.2147/JBM.S19009. PMID: 22287864.
 
40.
Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N. (2015), Venous thromboembolism in cancer patients: an underestimated major health problem, World J Surg Oncol, 13:204. doi:10.1186/s12957-015-0592-8. PMID: 26092573.
 
41.
Kontovazainitis CG, Gialamprinou D, Theodoridis T, Mitsiakos G. (2024), Hemostasis in Pre-Eclamptic Women and Their Offspring: Current Knowledge and Hemostasis Assessment with Viscoelastic Tests, Diagnostics (Basel), 14(3) doi:10.3390/diagnostics14030347. PMID: 38337863.
 
42.
Kreidy R. (2014), Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease, Int J Vasc Med, 2014:859726. doi:10.1155/2014/859726. PMID: 25057415.
 
43.
Ku SK, Lee W, Kang M, Bae JS. (2015), Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa, Arch Pharm Res, 38(6):1080-9. doi:10.1007/s12272-014-0501-7. PMID: 25325928.
 
44.
Kubatka P, Mazurakova A, Koklesova L, Samec M, Sokol J, Samuel SM, Kudela E, Biringer K, Bugos O, Pec M, Link B, Adamkov M, Smejkal K, Busselberg D, Golubnitschaja O. (2022), Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine, EPMA J, 13(3):407-431. doi:10.1007/s13167-022-00293-2. PMID: 35990779.
 
45.
Lamarche B, Astrup A, Eckel RH, Feeney E, Givens I, Krauss RM, Legrand P, Micha R, Michalski MC, Soedamah-Muthu S, Sun Q, Kok FJ. (2025), Regular-fat and low-fat dairy foods and cardiovascular diseases: perspectives for future dietary recommendations, Am J Clin Nutr, 121(5):956-964. doi:10.1016/j.ajcnut.2025.03.009. PMID: 40088974.
 
46.
Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, Sowers J. (2013), Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension, J Clin Hypertens (Greenwich), 15(1):14-33. doi:10.1111/jch.12049. PMID: 23282121.
 
47.
Leicester J. (2021), Rudolf Virchow and the Discovery of Cerebral Embolism, Stroke, 52(6):e266-e268. doi:10.1161/STROKEAHA.121.034443. PMID: 34029152.
 
48.
Lemanowicz J, Gawlinska K, Jaskulska I, Jaskulski D, Sar M. (2025), Flavonoids in Plants and Human Health: From Biosynthesis to Neurodevelopmental and Neurodegenerative Disorders, Molecules, 31(1) doi:10.3390/molecules31010066. PMID: 41515363.
 
49.
Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, Gong H, Hui C, Xu G, Li Y, Pan L, Zhang B, Shan G. (2017), The association between smoking and blood pressure in men: a cross-sectional study, BMC Public Health, 17(1):797. doi:10.1186/s12889-017-4802-x. PMID: 29017534.
 
50.
Li Z, Delaney MK, O'Brien KA, Du X. (2010), Signaling during platelet adhesion and activation, Arterioscler Thromb Vasc Biol, 30(12):2341-9. doi:10.1161/ATVBAHA.110.207522. PMID: 21071698.
 
51.
Liao L, Li X, Xu H, Tang J, Li B, Tang Y, Xie F. (2025), Systematic analysis of the interaction mechanism between platelets and coronary heart disease: from molecular pathways to new strategies for plant based antiplatelet therapy, Front Pharmacol, 16:1586265. doi:10.3389/fphar.2025.1586265. PMID: 40529502.
 
52.
Litvinov RI, Weisel JW. (2023), Blood clot contraction: Mechanisms, pathophysiology, and disease, Res Pract Thromb Haemost, 7(1):100023. doi:10.1016/j.rpth.2022.100023. PMID: 36760777.
 
53.
Loitongbam L, Surin WR. (2024), The Rising Burden of Cardiovascular Disease and Thrombosis in India: An Epidemiological Review, Cureus, 16(11):e73786. doi:10.7759/cureus.73786. PMID: 39687821.
 
54.
Lowe GD. (2003), Virchow's triad revisited: abnormal flow, Pathophysiol Haemost Thromb, 33(5-6):455-7. doi:10.1159/000083845. PMID: 15692260.
 
55.
Luyendyk JP, Schoenecker JG, Flick MJ. (2019), The multifaceted role of fibrinogen in tissue injury and inflammation, Blood, 133(6):511-520. doi:10.1182/blood-2018-07-818211. PMID: 30523120.
 
56.
Mannan MA, Khatun A, Khan MF. (2017), Antinociceptive effect of methanol extract of Dalbergia sissoo leaves in mice, BMC Complement Altern Med, 17(1):72. doi:10.1186/s12906-017-1565-y. PMID: 28114964.
 
57.
Mari D, Ogliari G, Castaldi D, Vitale G, Bollini EM, Lio D. (2008), Hemostasis and ageing, Immun Ageing, 5:12. doi:10.1186/1742-4933-5-12. PMID: 18947391.
 
58.
Maroyi A. (2023), Medicinal Uses of the Fabaceae Family in Zimbabwe: A Review, Plants (Basel), 12(6) doi:10.3390/plants12061255. PMID: 36986943.
 
59.
Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Merisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. (2016), Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development, Int J Obstet Anesth, 25:75-8. doi:10.1016/j.ijoa.2015.09.006. PMID: 26597405.
 
60.
Mendes-Silva W, Assafim M, Ruta B, Monteiro RQ, Guimaraes JA, Zingali RB. (2003), Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor, Thromb Res, 112(1-2):93-8. doi:10.1016/j.thromres.2003.10.014. PMID: 15013279.
 
61.
Miceli G, Basso MG, Rizzo G, Pintus C, Tuttolomondo A. (2022), The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies, Int J Mol Sci, 23(23) doi:10.3390/ijms232314914. PMID: 36499242.
 
62.
Mlynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, Rysz J, Franczyk B. (2024), From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion, Int J Mol Sci, 25(13) doi:10.3390/ijms25137295. PMID: 39000400.
 
63.
Palta S, Saroa R, Palta A. (2014), Overview of the coagulation system, Indian J Anaesth, 58(5):515-23. doi:10.4103/0019-5049.144643. PMID: 25535411.
 
64.
Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira M. (2018), Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review, Phytother Res, 32(12):2323-2339. doi:10.1002/ptr.6178. PMID: 30117204.
 
65.
Periayah MH, Halim AS, Mat Saad AZ. (2017), Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis, Int J Hematol Oncol Stem Cell Res, 11(4):319-327. doi:https://www.ncbi.nlm.nih.gov/p.... PMID: 29340130.
 
66.
Pluta W, Lubkowska A, Dudzinska W. (2025), Vascular Endothelium in Health and Disease: Structure, Function, Assessment and Role in Metabolic Disorders, Vasc Health Risk Manag, 21:729-747. doi:10.2147/VHRM.S519426. PMID: 40927226.
 
67.
Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. (2011), Risk factors for venous and arterial thrombosis, Blood Transfus, 9(2):120-38. doi:10.2450/2010.0066-10. PMID: 21084000.
 
68.
Prospective Studies C, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. (2007), Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet, 370(9602):1829-39. doi:10.1016/S0140-6736(07)61778-4. PMID: 18061058.
 
69.
Ramjan A, Hossain M, Runa JF, Md H, Mahmodul I. (2014), Evaluation of thrombolytic potential of three medicinal plants available in Bangladesh, as a potent source of thrombolytic compounds, Avicenna J Phytomed, 4(6):430-6. doi: https://www.ncbi.nlm.nih.gov/p.... PMID: 25386407.
 
70.
Rezaianzadeh A, Namayandeh SM, Sadr SM. (2012), National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?, Int J Prev Med, 3(8):552-8. doi: https://www.ncbi.nlm.nih.gov/p.... PMID: 22973485.
 
71.
Sahu AK, Dinesh D, Verma VK, Prajapati V, Bhatia J, Arya DS. (2024), Therapeutic potential of Ficus benghalensis in thromboembolic disorders, J Ayurveda Integr Med, 15(4):100929. doi:10.1016/j.jaim.2024.100929. PMID: 39106616.
 
72.
Santiago LR, Asevedo EA, de Oliveira MEJ, Pereira KC, da Silva Trindade MF, Oliveira AGS, Rocha MA, Kang S, Rani A, Park MN, Tan MW, Syahputra RA, Kim B, de Azambuja Ribeiro RIM. (2026), Artificial intelligence-based screening of phytochemicals for targeted cancer therapy, Nat Prod Bioprospect, 16(1) doi:10.1007/s13659-026-00599-y. PMID: 42012749.
 
73.
Schneider DJ, Taatjes DJ, Howard DB, Sobel BE. (1999), Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk, J Am Coll Cardiol, 33(1):261-6. doi:10.1016/s0735-1097(98)00515-4. PMID: 9935039.
 
74.
Scridon A. (2022), Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications, Int J Mol Sci, 23(21) doi:10.3390/ijms232112772. PMID: 36361561.
 
75.
Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. (2020), Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety, Front Pharmacol, 11:422. doi:10.3389/fphar.2020.00422. PMID: 32317975.
 
76.
Smola-Dmochowska A, Smigiel-Gac N, Jelonek K, Lewicka-Brzoza K, Bojdol J, Dobrzynski P. (2026), Antithrombotic Polymers: A Narrative Review on Current and Future Strategies for Their Design, Synthesis, and Application, Int J Mol Sci, 27(2) doi:10.3390/ijms27021026. PMID: 41596670.
 
77.
Subramani B, Sathiyarajeswaran P. (2022), Current update on herbal sources of antithrombotic activity-a comprehensive review, Egypt J Intern Med, 34(1):26. doi:10.1186/s43162-021-00090-9. PMID: 35283622.
 
78.
Suri S, Kumar V, Kumar S, Goyal A, Tanwar B, Kaur J, Kaur J. (2020), DASH Dietary Pattern: A Treatment for Non-communicable Diseases, Curr Hypertens Rev, 16(2):108-114. doi:10.2174/1573402115666191007144608. PMID: 31589127.
 
79.
Thomas DP, Roberts HR. (1997), Hypercoagulability in venous and arterial thrombosis, Ann Intern Med, 126(8):638-44. doi:10.7326/0003-4819-126-8-199704150-00009. PMID: 9103132.
 
80.
Varrias D, Spanos M, Kokkinidis DG, Zoumpourlis P, Kalaitzopoulos DR. (2023), Venous Thromboembolism in Pregnancy: Challenges and Solutions, Vasc Health Risk Manag, 19:469-484. doi:10.2147/VHRM.S404537. PMID: 37492280.
 
81.
Vazhappilly CG, Ansari SA, Al-Jaleeli R, Al-Azawi AM, Ramadan WS, Menon V, Hodeify R, Siddiqui SS, Merheb M, Matar R, Radhakrishnan R. (2019), Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases, Inflammopharmacology, 27(5):863-869. doi:10.1007/s10787-019-00612-6. PMID: 31309484.
 
82.
Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. (2004), Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways, Mol Med, 10(1-6):6-11. doi:10.2119/2003-00047.versteeg. PMID: 15502877.
 
83.
Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. (2024), Cardiovascular disease and cancer: shared risk factors and mechanisms, Nat Rev Cardiol, 21(9):617-631. doi:10.1038/s41569-024-01017-x. PMID: 38600368.
 
84.
Wolberg AS, Aleman MM, Leiderman K, Machlus KR. (2012), Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited, Anesth Analg, 114(2):275-85. doi:10.1213/ANE.0b013e31823a088c. PMID: 22104070.
 
85.
Yang L, Cao C, Kantor ED, Nguyen LH, Zheng X, Park Y, Giovannucci EL, Matthews CE, Colditz GA, Cao Y. (2019), Trends in Sedentary Behavior Among the US Population, 2001-2016, JAMA, 321(16):1587-1597. doi:10.1001/jama.2019.3636. PMID: 31012934.
 
86.
Yau JW, Teoh H, Verma S. (2015), Endothelial cell control of thrombosis, BMC Cardiovasc Disord, 15:130. doi:10.1186/s12872-015-0124-z. PMID: 26481314.
 
ISSN:3108-2696
Journals System - logo
Scroll to top